Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Cerilliant
US Department of Justice
Teva
Deloitte
Julphar
Johnson and Johnson
McKinsey

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Beloranib

« Back to Dashboard

US Patents for Beloranib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Beloranib ➤ Try a Free Trial Methods of treating a subject with benign prostate hyperplasia Zafgen, Inc. (Cambridge, MA) ➤ Try a Free Trial
Beloranib ➤ Try a Free Trial Fumigillol compounds and methods of making and using same Zafgen, Inc. (Boston, MA) ➤ Try a Free Trial
Beloranib ➤ Try a Free Trial Fumagillol heterocyclic compounds and methods of making and using same Zafgen, Inc. (Boston, MA) ➤ Try a Free Trial
Beloranib ➤ Try a Free Trial Fumigillol compounds and methods of making and using same Zafgen, Inc. (Boston, MA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Beloranib

Drugname Country Document Number Estimated Expiration Related US Patent
Beloranib World Intellectual Property Organization (WIPO) 2011085198 2030-01-08 ➤ Try a Free Trial
Beloranib Australia 2013259620 2032-05-09 ➤ Try a Free Trial
Beloranib Brazil 112014027981 2032-05-09 ➤ Try a Free Trial
Beloranib Canada 2873574 2032-05-09 ➤ Try a Free Trial
Beloranib China 104364251 2032-05-09 ➤ Try a Free Trial
Beloranib European Patent Office 2850079 2032-05-09 ➤ Try a Free Trial
Beloranib Japan 2015516427 2032-05-09 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
McKesson
Mallinckrodt
Daiichi Sankyo
Citi
Deloitte
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.